Paper41265652
The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3.
Patel C and 3 others. Neurotoxicology, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3. Papers, record 41265652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41265652
- Cell line
- hCMEC/D330 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Blood-Brain Barrier | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Endothelial Cells | Major topic |
| Animals | |
| Humans | |
| Rats | |
| Cell Line | |
| Rats, Sprague-Dawley | |
| Cytokines |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA293210 | NCI NIH HHS | United States | R01CA293210 | PubMed and NIH | NIH RePORTER |
| T32 GM135141 | NIGMS NIH HHS | United States | T32GM135141 | PubMed and NIH | NIH RePORTER |
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38676932 | Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis. | Cancer | 2024 | https://conductscience.org/library/papers/38676932 | PubMed |
| 2 | 8887554 | FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. | EMBO J | 1996 | https://conductscience.org/library/papers/8887554 | PubMed |
| 3 | 11018070 | VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. | J Clin Invest | 2000 | https://conductscience.org/library/papers/11018070 | PubMed |
| 4 | 38465668 | Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy. | J Int Neuropsychol Soc | 2024 | https://conductscience.org/library/papers/38465668 | PubMed |
| 5 | 31275302 | Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update. | Front Immunol | 2019 | https://conductscience.org/library/papers/31275302 | PubMed |
| 6 | 30963442 | Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling. | Mol Neurobiol | 2019 | https://conductscience.org/library/papers/30963442 | PubMed |
| 7 | 27367824 | Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. | Int J Cancer | 2016 | https://conductscience.org/library/papers/27367824 | PubMed |
| 8 | 37237920 | Dietary Polyphenols as a Protection against Cognitive Decline: Evidence from Animal Experiments; Mechanisms and Limitations. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37237920 | PubMed |
| 9 | 7595753 | Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. | J Neurooncol | 1995 | https://conductscience.org/library/papers/7595753 | PubMed |
| 10 | 30953771 | Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment. | Brain Behav Immun | 2019 | https://conductscience.org/library/papers/30953771 | PubMed |
| 11 | 27566778 | A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. | Genes Dev | 2016 | https://conductscience.org/library/papers/27566778 | PubMed |
| 12 | 36289516 | Development of a multicellular in vitro model of the meningeal blood-CSF barrier to study Neisseria meningitidis infection. | Fluids Barriers CNS | 2022 | https://conductscience.org/library/papers/36289516 | PubMed |
| 13 | 37243381 | Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. | Aging Cell | 2023 | https://conductscience.org/library/papers/37243381 | PubMed |
| 14 | 18523641 | Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. | PLoS One | 2008 | https://conductscience.org/library/papers/18523641 | PubMed |
| 15 | 35049413 | IL-6/IFN-γ double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro. | Hum Vaccin Immunother | 2022 | https://conductscience.org/library/papers/35049413 | PubMed |
| 16 | 34100420 | Research advances on how metformin improves memory impairment in "chemobrain". | Neural Regen Res | 2022 | https://conductscience.org/library/papers/34100420 | PubMed |
| 17 | 22338017 | Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22338017 | PubMed |
| 18 | 26336377 | Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate. | J Can Acad Child Adolesc Psychiatry | 2015 | https://conductscience.org/library/papers/26336377 | PubMed |
| 19 | 24497266 | The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia. | Psychooncology | 2014 | https://conductscience.org/library/papers/24497266 | PubMed |
| 20 | 31824303 | The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31824303 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42754772 | Cancer therapy-related cognitive impairment, part 1: an integrative clinical-mechanistic framework from phenotypes to convergent neurobiological pathways. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/42754772 | PubMed |
| 42726439 | Cancer therapy-related cognitive impairment, part 2: from bench to bedside-and back: why candidate therapies for cancer therapy-related cognitive impairment fail to translate. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/42726439 | PubMed |
| 42667072 | Unlocking the brain: Biodistribution insights into tween 80 nanoliposomes in healthy brains. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42667072 | PubMed |
| 42646762 | Indoxyl Sulfate-Mediated Blood-Brain Barrier Damage in Chronic Kidney Disease. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42646762 | PubMed |
| 42293386 | A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42293386 | PubMed |
| 41886471 | APOE4 and doxorubicin impair inhibitory interneuron function and homeostatic regulation in the entorhinal cortex. | PLoS One | 2026 | https://conductscience.org/library/papers/41886471 | PubMed |
| 41744885 | Multimodal Cancer Therapy and Accelerated Brain Aging: Mechanisms, Biomarkers, and Clinical Consequences. | Curr Oncol | 2026 | https://conductscience.org/library/papers/41744885 | PubMed |
| 41436539 | Influence of ApoE genotype on doxorubicin-induced cognitive impairment in juvenile rats. | Sci Rep | 2025 | https://conductscience.org/library/papers/41436539 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL5 | 6352 | PubTator's text mining | https://conductscience.org/library/genes/6352 | NCBI Gene |
| CREB1 | 1385 | PubTator's text mining | https://conductscience.org/library/genes/1385 | NCBI Gene |
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41265652
GET https://conductscience.org/api/papers/v1/41265652/references?page=2